<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Statement on the US support for TRIPS Waiver</title>
    <link>https://www.taxtmi.com/news?id=24012</link>
    <description>Support for a temporary TRIPS waiver is advanced to relax certain intellectual property obligations at the WTO, enabling rapid scaling up of manufacturing, technology diffusion, and broader access to Covid 19 vaccines and essential medical products in developing countries; the proposal seeks consensus-based approval to remove barriers to production and distribution during the public health emergency.</description>
    <language>en-us</language>
    <pubDate>Fri, 07 May 2021 12:26:52 +0530</pubDate>
    <lastBuildDate>Fri, 07 May 2021 12:26:52 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=643719" rel="self" type="application/rss+xml"/>
    <item>
      <title>Statement on the US support for TRIPS Waiver</title>
      <link>https://www.taxtmi.com/news?id=24012</link>
      <description>Support for a temporary TRIPS waiver is advanced to relax certain intellectual property obligations at the WTO, enabling rapid scaling up of manufacturing, technology diffusion, and broader access to Covid 19 vaccines and essential medical products in developing countries; the proposal seeks consensus-based approval to remove barriers to production and distribution during the public health emergency.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Fri, 07 May 2021 12:26:52 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=24012</guid>
    </item>
  </channel>
</rss>